Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BLND
BLND logo

BLND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Blend Labs Inc (BLND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.820
1 Day change
11.66%
52 Week Range
4.490
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Blend Labs Inc (BLND) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the company's financial performance shows significant declines in revenue, net income, and EPS. The options data suggests a lack of significant bullish sentiment, and there are no strong positive catalysts or recent influential trades to support a buy decision. For a long-term investor, it may be prudent to wait for clearer signs of financial recovery or stronger market sentiment before investing.

Technical Analysis

The MACD histogram is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 46.134, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upside potential in the short term, with resistance at 1.789 and support at 1.598.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
7

Positive Catalysts

  • The MACD shows mild bullish momentum, and the gross margin increased slightly YoY to 74.42%.

Neutral/Negative Catalysts

  • Revenue, net income, and EPS have all declined significantly YoY. Analysts have lowered price targets, and there are no significant insider or hedge fund trading trends. Additionally, the stock's technical indicators suggest limited upside in the near term.

Financial Performance

In Q3 2025, revenue dropped by -0.74% YoY to $32.86M, net income dropped by -196.62% YoY to $7.97M, and EPS dropped by -200.00% YoY to $0.03. Gross margin increased slightly to 74.42%, up 0.55% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Barclays recently lowered the price target on BLND to 450 GBp from 460 GBp, maintaining an Equal Weight rating. This reflects a neutral to slightly bearish sentiment among analysts.

Wall Street analysts forecast BLND stock price to rise
5 Analyst Rating
Wall Street analysts forecast BLND stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.630
sliders
Low
3
Averages
4.19
High
5.25
Current: 1.630
sliders
Low
3
Averages
4.19
High
5.25
Citizens
Aaron Kimson
Outperform -> NULL
downgrade
$7 -> $5
AI Analysis
2026-03-11
New
Reason
Citizens
Aaron Kimson
Price Target
$7 -> $5
AI Analysis
2026-03-11
New
downgrade
Outperform -> NULL
Reason
Citizens analyst Aaron Kimson lowered the firm's price target on Blend Labs to $5 from $7 and keeps an Outperform rating on the shares. The company reported "strong" Q4 results but its Q1 guidance is "disappointing," the analyst tells investors in a research note. Citizens reduced estimates but says the financial institution customers Blend serves will want to stay in the mortgage business.
Wells Fargo
Overweight
downgrade
$5 -> $4
2026-03-11
New
Reason
Wells Fargo
Price Target
$5 -> $4
2026-03-11
New
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on Blend Labs to $4 from $5 and keeps an Overweight rating on the shares. The firm notes Q4 revenue was in line, as better-than-expected mortgage was offset by softness in consumer banking. While a longer than expected journey, Wells sees Blend Labs holding stable and expects growth to ultimately bounce back as mortgage volumes improve.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BLND
Unlock Now

People Also Watch